Translational Research Institute, The University of Queensland Diamantina Institute, PO Box 6116, Buranda Queensland 4102, Australia.
Curr Opin Virol. 2011 Oct;1(4):268-79. doi: 10.1016/j.coviro.2011.07.007.
We compare the design, mechanism of action, and clinical efficacy of two recently licensed paradigm shifting vaccines. Zostavax is the first vaccine licensed to prevent disease in patients already infected with a pathogen, and is contrasted with Gardasil and Cervarix, the first vaccines designed and licensed specifically to prevent cancers.
我们比较了两种最近获得许可的具有开创性的疫苗的设计、作用机制和临床疗效。Zostavax 是第一种获准用于预防已感染病原体的患者疾病的疫苗,与之形成对比的是 Gardasil 和 Cervarix,这两种疫苗是专门为预防癌症而设计和许可的第一种疫苗。